Summary
For Year 2026-27, Hester Biosciences reports the following shareholding: Total Promoters at 53.73%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.38%, Domestic Institutional Investors at 0%, and Retail at 45.89%. This breakdown provides a quick snapshot of ownership distribution for Hester Biosciences in 2026-27.
Hester Biosciences FAQs
As of 04-2026, the promoter shareholding in Hester Biosciences stands at 53.73% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Hester Biosciences is 0.38% and 0% respectively.
The retail shareholding of the Hester Biosciences is 45.89%.
Changes in shareholding patterns of Hester Biosciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Hester Biosciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Hester Biosciences Associated Pages
